1. K A, J L, T H, PE Z. The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. Int J Mol Sci [Internet]. 2020 May 1 [cited 2021 Oct 31];21(9). Available from: https://pubmed.ncbi.nlm.nih.gov/32392889/
2. MT H, PS S. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr [Internet]. 2000 [cited 2021 Oct 31];32(3):301–8. Available from: https://pubmed.ncbi.nlm.nih.gov/11768314/
3. H K, F T, H O, R M, K Y, Y O, et al. Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. Ann Thorac Surg [Internet]. 2002 [cited 2021 Oct 31];73(4):1060–4. Available from: https://pubmed.ncbi.nlm.nih.gov/11996241/
4. nm23: Unraveling its biological function in cell differentiation - Lombardi - 2000 - Journal of Cellular Physiology - Wiley Online Library [Internet]. [cited 2021 Oct 31]. Available from: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-4652(200002)182:2%3C144::AID-JCP2%3E3.0.CO;2-6
5. G S, N R, I P, S Z, M T, S F, et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinforma [Internet]. 2016 [cited 2021 Oct 31];54:1.30.1-1.30.33. Available from: https://pubmed.ncbi.nlm.nih.gov/27322403/
6. R X, Y P, B H, X L, Y C, H P. Metastasis suppressor NME1 promotes non-homologous end joining of DNA double-strand breaks. DNA Repair (Amst) [Internet]. 2019 May 1 [cited 2021 Oct 31];77:27–35. Available from: https://pubmed.ncbi.nlm.nih.gov/30875636/
7. Yazdani B, Jazini M, Jabbari N, Karami M, Rahimirad S, Azadeh M, et al. Altered expression level of ACSM5 in breast cancer: An integrative analysis of tissue biomarkers with diagnostic potential. Gene Reports. 2021 Mar 1;22:100992.
8. Azadeh M, Salehzadeh A, Ghaedi K, Sasani ST. Decreased expression level of long non-coding RNA CCAT1, was observed in breast cancer tissue of an Isfahanian population (Iran). Gene Reports. 2021 Jun 1;23:101154.
9. F B, H MT, M MN, K G, M A. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3’-untranslated region of ErbB4 in breast cancer. Mol Med Rep [Internet]. 2016 May 1 [cited 2021 Oct 31];13(5):4494–8. Available from: https://pubmed.ncbi.nlm.nih.gov/27035115/
10. Rouigari M, Dehbashi M, Tabatabaeian H, Ghaedi K, Mohammadynejad P, Azadeh M. Evaluation of the Expression Level and Hormone Receptor Association of miR-126 in Breast Cancer. Indian J Clin Biochem 2018 344 [Internet]. 2018 Jun 16 [cited 2021 Oct 31];34(4):451–7. Available from: https://link.springer.com/article/10.1007/s12291-018-0766-6
11. C L, L F, M I, O P, XY L, H B-K, et al. Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance. Oncogene [Internet]. 2021 Jun 10 [cited 2021 Oct 31];40(23):4019–32. Available from: https://pubmed.ncbi.nlm.nih.gov/34012098/
12. The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma - PubMed [Internet]. [cited 2021 Oct 31]. Available from: https://pubmed.ncbi.nlm.nih.gov/25048347/
13. YH L. Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer. Int J Mol Sci [Internet]. 2020 Apr 2 [cited 2021 Oct 31];21(8). Available from: https://pubmed.ncbi.nlm.nih.gov/32331347/
14. J X, KJ W, QJ J, XF D. Roles of miRNA and lncRNA in triple-negative breast cancer. J Zhejiang Univ Sci B [Internet]. 2020 Sep 1 [cited 2021 Oct 31];21(9):673–89. Available from: https://pubmed.ncbi.nlm.nih.gov/32893525/
15. YT T, JF L, T L, JJ L, RH X, HQ J. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (London, England) [Internet]. 2021 Feb 1 [cited 2021 Oct 31];41(2):109–20. Available from: https://pubmed.ncbi.nlm.nih.gov/33119215/
16. L V, P A, M K. Circulating miRNA analysis for cancer diagnostics and therapy. Mol Aspects Med [Internet]. 2020 Apr 1 [cited 2021 Oct 31];72. Available from: https://pubmed.ncbi.nlm.nih.gov/31635843/
17. AP FC, KT U, JC S. Arsenic-induced changes in miRNA expression in cancer and other diseases. Toxicol Appl Pharmacol [Internet]. 2020 Dec 15 [cited 2021 Oct 31];409. Available from: https://pubmed.ncbi.nlm.nih.gov/33127375/
18. C C, SF M, P D, ST A, H J, L O, et al. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis [Internet]. 2013 Oct [cited 2021 Oct 31];34(10):2300–8. Available from: https://pubmed.ncbi.nlm.nih.gov/23740839/
19. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res [Internet]. 2015 Apr 20 [cited 2021 Oct 31];43(7):e47–e47. Available from: https://academic.oup.com/nar/article/43/7/e47/2414268
20. Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics [Internet]. 2007 Jul 15 [cited 2021 Oct 31];23(14):1846–7. Available from: https://academic.oup.com/bioinformatics/article/23/14/1846/190290
21. Karagkouni D, Paraskevopoulou MD, Tastsoglou S, Skoufos G, Karavangeli A, Pierros V, et al. DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts. Nucleic Acids Res [Internet]. 2020 Jan 8 [cited 2021 Oct 31];48(D1):D101–10. Available from: https://academic.oup.com/nar/article/48/D1/D101/5626521
22. Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods 2015 128 [Internet]. 2015 Jul 30 [cited 2021 Oct 31];12(8):697–697. Available from: https://www.nature.com/articles/nmeth.3485
23. H D, C S, P P, N G. miRWalk--database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform [Internet]. 2011 Oct [cited 2021 Oct 31];44(5):839–47. Available from: https://pubmed.ncbi.nlm.nih.gov/21605702/
24. Xie Z, Bailey A, Kuleshov M V., Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene Set Knowledge Discovery with Enrichr. Curr Protoc [Internet]. 2021 Mar 1 [cited 2021 Oct 31];1(3):e90. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/cpz1.90
25. MV K, MR J, AD R, NF F, Q D, Z W, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res [Internet]. 2016 Jul 8 [cited 2021 Oct 31];44(W1):W90–7. Available from: https://pubmed.ncbi.nlm.nih.gov/27141961/
26. EY C, CM T, Y K, Q D, Z W, GV M, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics [Internet]. 2013 Apr 15 [cited 2021 Oct 31];14. Available from: https://pubmed.ncbi.nlm.nih.gov/23586463/
27. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res [Internet]. 2000 Jan 1 [cited 2021 Oct 31];28(1):27–30. Available from: https://academic.oup.com/nar/article/28/1/27/2384332
28. M K, M F, Y S, M I-W, M T. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res [Internet]. 2021 Jan 8 [cited 2021 Oct 31];49(D1):D545–51. Available from: https://pubmed.ncbi.nlm.nih.gov/33125081/
29. B J, L M, G V, C G, P L, A F, et al. The reactome pathway knowledgebase. Nucleic Acids Res [Internet]. 2020 Jan 1 [cited 2021 Oct 31];48(D1):D498–503. Available from: https://pubmed.ncbi.nlm.nih.gov/31691815/
30. A F, F K, G V, K S, P M-G, P P, et al. Reactome graph database: Efficient access to complex pathway data. PLoS Comput Biol [Internet]. 2018 Jan 1 [cited 2021 Oct 31];14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/29377902/
31. P S, A M, O O, NS B, JT W, D R, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res [Internet]. 2003 Nov [cited 2021 Oct 31];13(11):2498–504. Available from: https://pubmed.ncbi.nlm.nih.gov/14597658/
32. Sun C-B, Wang H-Y, Han X-Q, Liu Y-N, Wang M-C, Zhang H-X, et al. LINC00511 promotes gastric cancer cell growth by acting as a ceRNA. http://www.wjgnet.com/ [Internet]. 2020 Apr 15 [cited 2021 Oct 31];12(4):394–404. Available from: https://www.wjgnet.com/1948-5204/full/v12/i4/394.htm
33. Hu P, Cui H, Lei T, Li S, Mai E, Jia F. <p>Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma</p>. Onco Targets Ther [Internet]. 2019 Nov 8 [cited 2021 Oct 31];12:9367–76. Available from: https://www.dovepress.com/linc00511-indicates-a-poor-prognosis-of-liver-hepatocellular-carcinoma-peer-reviewed-fulltext-article-OTT
34. S L, W G, H G, C W, S Y, X X. LINC00511 exacerbated T-cell acute lymphoblastic leukemia via miR-195-5p/LRRK1 axis. Biosci Rep [Internet]. 2020 May 1 [cited 2021 Oct 31];40(5). Available from: https://pubmed.ncbi.nlm.nih.gov/32242897/
35. J X, G C, Y Z, Z H, X C, H G, et al. LINC00511 Promotes Osteosarcoma Tumorigenesis and Invasiveness through the miR-185-3p/E2F1 Axis. Biomed Res Int [Internet]. 2020 [cited 2021 Oct 31];2020. Available from: https://pubmed.ncbi.nlm.nih.gov/32964019/
36. G L, Y L, Y M, J L, Y C, Q J, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res [Internet]. 2018 Nov 27 [cited 2021 Oct 31];37(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30482236/
37. L L, Y Z, AM L, Y F, Y C. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185. Eur Rev Med Pharmacol Sci [Internet]. 2019 [cited 2021 Oct 31];23(17):7457–68. Available from: https://pubmed.ncbi.nlm.nih.gov/31539133/
38. Long BM. Long Noncoding RNA LINC00511 Promotes Cell Growth And Invasion In Triple-Negative Breast Cancer By Interacting With Snail [Retraction]. Cancer Manag Res [Internet]. 2019 Sep 23 [cited 2021 Oct 31];11:8603–8603. Available from: https://europepmc.org/articles/PMC6765067
39. Liu Y, Ye F. Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma. PeerJ [Internet]. 2019 Jul 22 [cited 2021 Oct 31];7(7):e7380. Available from: https://peerj.com/articles/7380
40. Mathias C, Zambalde EP, Rask P, Gradia DF, de Oliveira JC. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know? Clin Genet. 2019 May 1;95(5):558–68.
41. B P, R B, M R, A F, M C, T M, et al. Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel. Sci Rep [Internet]. 2019 Dec 1 [cited 2021 Oct 31];9(1). Available from: https://pubmed.ncbi.nlm.nih.gov/31624308/
42. PJ G, YC S, SR H, YF Z, XN Y, JJ X, et al. Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer. Front Oncol [Internet]. 2020 Dec 2 [cited 2021 Oct 31];10. Available from: https://pubmed.ncbi.nlm.nih.gov/33344235/
43. S N, A G, M C, A T. Hypoxia-Induced miR-148a Downregulation Contributes to Poor Survival in Colorectal Cancer. Front Genet [Internet]. 2021 May 31 [cited 2021 Oct 31];12. Available from: https://pubmed.ncbi.nlm.nih.gov/34135940/
44. K Q, X Z, T L, T L, Z W, S L, et al. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Sci Rep [Internet]. 2017 Dec 1 [cited 2021 Oct 31];7(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28490741/
45. Tavousi N, Taqizadeh Q, Fanavari Z, Nasiriyan E, Tabaeian P, Rezaei M, et al. ADAMTS5 modulates breast cancer development as a diagnostic biomarker and potential tumor suppressor, regulating by BAIAP2-AS1, VTI1B, CRNDE, and hsa-miR-135b-3p: integrated systems biology and experimental approach. 2022 Jul 27 [cited 2022 Aug 6]; Available from: https://www.researchsquare.com
46. Donyavi MH, Salehi-Mazandarani S, Nikpour P. Comprehensive competitive endogenous RNA network analysis reveals EZH2-related axes and prognostic biomarkers in hepatocellular carcinoma. Iran J Basic Med Sci [Internet]. 2022 Mar 1 [cited 2022 Aug 6];25(3):286–94. Available from: https://ijbms.mums.ac.ir/article_19835.html